Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROCEPT BioRobotics Corp Director's Dealing 2022

Apr 4, 2022

31665_dirs_2022-04-04_16e7d778-3dde-4177-b500-122ea2d70ba5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PROCEPT BioRobotics Corp (PRCT)
CIK: 0001588978
Period of Report: 2022-03-31

Reporting Person: Zadno Reza (Director, President, CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-31 Common Stock A 39312 $29.38 Acquired 95337 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-03-31 Stock Option (Right to Buy) $34.99 A 79584 Acquired 2032-03-30 Common Stock (79584.0) Direct

Footnotes

F1: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 15, 2023, with one-quarter of the remaining RSUs vesting annually on each of the second, third, and fourth anniversary thereof, subject to the Reporting Person continuing as a service provider through such date.

F2: The Stock option was granted on March 31, 2022 and vests 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date.